The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
Friday, February 5, 2016 10:00 AM - 11:00 AM GMT Standard Time
Please join the meeting from your computer, tablet or smartphone. https://attendee.gotowebinar.com/register/1417555634070303745 Please ensure you allow sufficient time to install the GoToWebinar software (approximately 2 minutes).
After clicking the URL you will be sent a confirmation email giving you international phone numbers.
Scientific Meetings
Discussion on the Potential Merger With The Royal Statistical Society
The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
Friday, February 5, 2016 10:00 AM - 11:00 AM GMT Standard Time
Please join the meeting from your computer, tablet or smartphone. https://attendee.gotowebinar.com/register/1417555634070303745 Please ensure you allow sufficient time to install the GoToWebinar software (approximately 2 minutes).
After clicking the URL you will be sent a confirmation email giving you international phone numbers.
Training Courses
Discussion on the Potential Merger With The Royal Statistical Society
The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
Friday, February 5, 2016 10:00 AM - 11:00 AM GMT Standard Time
Please join the meeting from your computer, tablet or smartphone. https://attendee.gotowebinar.com/register/1417555634070303745 Please ensure you allow sufficient time to install the GoToWebinar software (approximately 2 minutes).
After clicking the URL you will be sent a confirmation email giving you international phone numbers.
Journal Club
Discussion on the Potential Merger With The Royal Statistical Society
The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
Friday, February 5, 2016 10:00 AM - 11:00 AM GMT Standard Time
Please join the meeting from your computer, tablet or smartphone. https://attendee.gotowebinar.com/register/1417555634070303745 Please ensure you allow sufficient time to install the GoToWebinar software (approximately 2 minutes).
After clicking the URL you will be sent a confirmation email giving you international phone numbers.
Webinars
Discussion on the Potential Merger With The Royal Statistical Society
The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
Friday, February 5, 2016 10:00 AM - 11:00 AM GMT Standard Time
Please join the meeting from your computer, tablet or smartphone. https://attendee.gotowebinar.com/register/1417555634070303745 Please ensure you allow sufficient time to install the GoToWebinar software (approximately 2 minutes).
After clicking the URL you will be sent a confirmation email giving you international phone numbers.
Careers Meetings
Discussion on the Potential Merger With The Royal Statistical Society
The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
Friday, February 5, 2016 10:00 AM - 11:00 AM GMT Standard Time
Please join the meeting from your computer, tablet or smartphone. https://attendee.gotowebinar.com/register/1417555634070303745 Please ensure you allow sufficient time to install the GoToWebinar software (approximately 2 minutes).
After clicking the URL you will be sent a confirmation email giving you international phone numbers.
Upcoming Events
PSI Webinar: Development of Gene Therapies: Strategic, Scientific, Regulatory and Access Considerations
This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Introduction to Industry Training (ITIT) Course - 2024/2025
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
PSI Training Course: Regulatory Guidelines for Statisticians
This 2-day course is designed to provide a comprehensive understanding of the regulatory guidelines affecting statisticians in the pharmaceutical industry, including the latest updates in the field. The course will cover key International Council for Harmonisation (ICH) guidelines and other key regional regulatory agency documents.
In this event, we’ll start with a general introduction to hierarchical composite endpoints and an overview of common analysis methods including win ratio, win odds, and net benefit. Then, the practical considerations will be illustrated through case studies from clinical trials in heart failure and chronic kidney disease. We conclude with a discussion and a Q&A.
Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Statisticians in the Pharmaceutical Industry Executive Office: c/o MCI UK Ltd | Unit 24/22 South | Building 4000 | Langstone Park| Langstone Road | Havant | PO9 1SA | UK